HRH1 and seasonal allergic rhinitis: First, we used information from the Therapeutic Target Database (Zhou et al., 2022) to annotate each compound with its indications (e.g. triprolidine is used to treat hay fever), targets (e.g. triprolidine targets the histamine H1 receptor), and the pathways it affects through its targets (e.g. triprolidine affects the ‘inflammatory mediator regulation of TRP channels’).